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Abstract
Background: Prednisone, one of the most highly prescribed drugs, has well characterized effects
on gene transcription mediated by the glucocorticoid receptor. These effects are typically
occurring on the scale of hours. Prednisone also has a number of non-transcriptional effects
(occurring on minutes scale) on protein signaling, yet these are less well studied. We sought to
expand the understanding of acute effects of prednisone action on cell signaling using a combination
of SILAC strategy and subcellular fractionations from C2C12 myotubes.
Results: De novo translation of proteins was inhibited in both SILAC labeled and unlabeled C2C12
myotubes. Unlabeled cells were exposed to prednisone while SILAC labeled cells remained
untreated. After 0, 5, 15, and 30 minutes of prednisone exposure, labeled and unlabeled cells were
mixed at 1:1 ratios and fractionated into cytosolic and nuclear fractions. A total of 534 proteins in
the cytosol and 626 proteins in the nucleus were identified and quantitated, using 3 or more
peptides per protein with peptide based probability ≤ 0.001. We identified significant increases (1.7-
to 3.1- fold) in cytoplasmic abundance of 11 ribosomal proteins within 5 minutes of exposure, all
of which returned to baseline by 30 min. We hypothesized that these drug-induced acute changes
in the subcellular localization of the cell's protein translational machinery could lead to altered
translation of quiescent RNAs. To test this, de novo protein synthesis was assayed after 15 minutes
of drug exposure. Quantitative fluorography identified 16 2D gel spots showing rapid changes in
translation; five of these were identified by MS/MS (pyruvate kinase, annexin A6 isoform A and
isoform B, nasopharyngeal epithelium specific protein 1, and isoform 2 of Replication factor C
subunit 1), and all showed the 5' terminal oligopyrimidine motifs associated with mRNA
sequestration to and from inactive mRNA pools.
Conclusion: We describe novel approaches of subcellular proteomic profiling and assessment of
acute changes on a minute-based time scale. These data expand the current knowledge of acute,
non-transcriptional activities of glucocorticoids, including changes in protein subcellular
localization, altered translation of quiescent RNA pools, and PKC-mediated cytoskeleton
remodeling.
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Background
The synthetic glucocorticoid prednisone is one of the
most widely prescribed drugs worldwide due to its potent
immunosuppressive and anti-inflammatory effects [1].
Prednisone treatment remains the standard of care for
treatment of a variety of disorders including asthma, mus-
cular dystrophy, autoimmune disorders, and arthritis.
Other newer and more potent or targeted immunosup-
pressants have been tried in many of these disorders, but
they have been less efficacious than prednisone. However,
chronic use of prednisone is associated with significant
negative side effects. A greater understanding of pred-
nisone's molecular actions could help optimize treat-
ments that maximize efficacy while minimizing side
effects.
The best characterized effect of steroids is their ability to
bind soluble steroid hormone receptors, and then move
to the nucleus where the receptor complex directly binds
to promoter elements and mediates gene transcription. In
the case of glucocorticoids, there are well studied gluco-
corticoid response elements in target gene promoters that
are responsible for binding the ligand/receptor complex,
with downstream modulation of gene transcription [2,3].
Synthetic glucocorticoids have been shown in multiple
tissues to decrease membrane fluidity by altering the cho-
lesterol/phospholipids ratio [4-6]. While downstream
effects of glucocorticoids on gene transcription and regu-
lation have been well characterized, their non-transcrip-
tional signaling response is poorly understood.
Prednisone has been shown to acutely activate protein
kinase C (PKC) dependent mitogen activated protein
kinase pathway via putative G-protein coupled receptors
in immune, brain, and lung cells [7-10]. Additionally, glu-
cocorticoids have been reported to translocate annexin A1
and 5-lipoxygenase and S100A11 to the cytoskeleton in
response to glucocorticoid exposure [8,11,12].
We have reported the transcriptional effects of glucocorti-
coids in muscle cells using in vivo time series data [13].
Methods for profiling proteins are beginning to emerge,
and we envisioned that generating proteomic profiling
time series data on the minute time scale, integrated with
mRNA changes on the minutes time scale, would enable a
systems biology understanding of the mechanisms of
action of prednisone. Subcellular proteomic profiling to
gauge protein translocation on the minute time scale
would add important information regarding the effects of
prednisone on cell signaling.
To date, protein translocation studies have involved in
vivo generation of fluorescent analogs of a target protein
followed by its microinjection into live cells [14-16]. The
discovery of GFP (and its variants) as an expression
reporter in 1997 facilitated the study of protein trafficking
[17]. However, this method has its limitations since only
a few proteins can be studied at any given time, and there
have been no reports in vertebrate cells of subcellular pro-
tein translocation on a more global scale. One form of
protein translocation is protein secretion to the extracellu-
lar milieu (secretome). Stable isotope labeling by amino
acid in cell culture (SILAC) has been successfully applied
to study the secretome in a pancreatic cancer cell line [18]
and human primary retinal pigment epithelial cells [19].
SILAC strategy has been also used successfully to generate
a number of protein profiles, measure kinetics of protein
turnover, describe protein-protein interactions, as well as
quantitative phosphoproteomics [20-22]. SILAC is one of
the most accurate methods for subcellular proteome pro-
filing because labeled and unlabeled cells can be mixed
before subcellular fractionation and protein extraction,
thus minimizing variation due to experimental handling.
Here, we implemented SILAC strategy to expand our
knowledge about intracellular protein translocation in
response to pharmacological doses of prednisone. We
used an acute time series experiment (0, 5, 15, and 30
minutes) to identify a series of rapid effects of prednisone
on protein abundance and subcellular location. These
changes were validated by documenting changes in trans-
lation of quiescent RNA pools, and cytoplasmic to nuclear
translocation of annexin A2. These data provide a poten-
tial mechanism underlying the previously reported inhib-
itory effect of prednisone on cell proliferation.
Results
SILAC and subcellular fractionation defines the protein 
translocation in response to prednisone
We devised a strategy and experimental method to profile
protein translocation in response to prednisone exposure
in vitro (Figure 1). The experimental model used was cul-
tured myogenic (muscle) cells (C2C12 myotubes) after
exposure to a pharmacological dose of prednisone for 0,
5, 15, and 30 minutes. To specifically study protein trans-
location and not de novo changes in protein synthesis, de
novo protein synthesis was inhibited with cycloheximide
throughout all experiments. The glucocorticoid receptor
bound to a ligand (i.e. cortisol, prednisone) is well known
to modulate transcriptional activity of target genes, and
thus secondarily influence protein abundance and locali-
zation. However, both the use of cycloheximide to inhibit
translation and short time frames largely rule out de novo
transcription as a significant factor in our studies. Most
transcription-mediated protein changes occur on the
order of hours, while we used minutes of prednisone
exposure [13]. Thus, our experimental design should
ensure that any changes in protein abundances in our sub-
cellular fraction are not due to alterations in translationProteome Science 2009, 7:26 http://www.proteomesci.com/content/7/1/26
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due to de novo mRNA or protein production known to
occur in response to prednisone.
Pairs of steroid-exposed and non-exposed cells from each
time point were mixed at 1:1 ratio (w/w), fractionated
into cytosolic and nuclear fractions using differential
detergent fractionation then processed for proteome pro-
filing as described in the methods section [23]. The
number of proteins identified and quantified for each
time point and fraction ranged from 316 to 404 for the
cytosolic fraction and 318 to 483 for the nuclear fraction.
We found small variances for the ratios of multiple pep-
tides mapping to the same parent protein, indicating the
accuracy of SILAC strategy. The percentage of overlapping
proteins identified across all four time points ranged from
55–71% and 31–47% in the cytosolic and nuclear frac-
tion respectively (see Additional file 1). The overall iden-
tification percentage rate was 41.8% for the cytosolic
fraction and 23.8% for the nuclear fraction. The nuclear 5
min time point had a higher number of proteins quanti-
fied compared to the other time points in both fractions,
exemplifying the issue of variability in performing repro-
ducible independent subcellular fractionation.
Prednisone drives acute changes in the cytoskeleton
We first analyzed the distributions of all protein ratios in
each fraction and time point. Figure 2 show the overall
ratio distribution of proteins in the cytosolic and nuclear
fractions at different time points following exposure to
prednisone. The distributions of ratios for T0 (control)
were quite narrow (T0 cytosol: δ = 0.21 and T0 nuclear: δ
= 0.22). Effects of the drug on protein ratios were statisti-
cally significant within 5 and 15 min of prednisone expo-
sure, with broadening of distributions relative to T0
(cytosol T5: δ = 0.50 (p-value < 0.0001; T15 δ = 0.41 (p-
value < 0.001) respectively and δ = 0.32 (p-value = 0.003)
and δ = 0.44 (p-value < 0.001) in the nuclear fraction. The
distributions at time 30 minutes narrowed considerably,
becoming more narrow compared to T0 (cytosol T30 δ =
0.12 (p-value = 0.01); nuclear T30 δ = 0.14 (p-value =
0.001)), suggesting that most protein localizations and/or
quantities were changed soon after prednisone applica-
tion, and that these protein changes largely returned to
baseline levels by 30 minutes.
We limited analyses to those proteins identified across all
time points for a specific fraction, and those proteins with
a set ratio and p-value cutoff. Since T0 ratios typically
ranged between 0.66 and 1.5, ratios outside this window
were considered significant. After filtering, the number of
differentially altered proteins was reduced from 223 pro-
teins to 53 proteins in the cytosolic fraction, and from 149
to 16 proteins in the nuclear fraction (see Additional file
2). Many of the most significant temporal changes were
seen in cytoskeleton-related proteins (Table 1). In addi-
Methodology for subcellular proteomic assessment in gluco- corticoid-exposed myogenic cells Figure 1
Methodology for subcellular proteomic assessment 
in glucocorticoid-exposed myogenic cells.
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tion to these proteins listed in the table, there was a signif-
icant decrease of myosin heavy chain 8, tropomyosin 1
and troponin C type 1 in either the cytosol or nucleus for
the first 15 minutes of exposure to prednisone. While
other cytoskeleton and cytoskeleton-associated proteins
such as alpha actinin 4, glutaredoxin 3, myoferlin, talin-1
and vimentin were significantly increased in either the
cytosol or nucleus for the first 15 min following pred-
nisone exposure. By 30 min, these proteins (with the
exception of tropomyosin 4) had returned to basal levels.
This suggests an acute cytoskeleton rearrangement in
prednisone-exposed cells versus unexposed cells.
Prednisone rapidly alters subcellular localization of mRNA 
translational members
A list of proteins showing significant changes in either the
cytosol or nuclear fractions (see Additional file 2) were
imported into GO-Getter http://bmf2.colorado.edu/go-
getter to obtain gene ontology analysis. The largest per-
centage (21.7%) of proteins from this list was categorized
as ribosomal proteins (data not shown). Eleven ribos-
omal proteins were found to be significantly increased in
the cytosolic fraction at 5 min following prednisone expo-
sure (Table 2; Figures 3 and 4). Increased ribosomal pro-
teins included subunits that form the 40S and 60S
ribosomal complex. All of these proteins shared a com-
mon transient increase at 5 min post-prednisone treat-
ment with a return to basal levels by 30 min post-
treatment. In addition to the ribosomal proteins, other
proteins involved in transcription/translation also had
altered subcellular localization, including elongation fac-
tor 1 alpha 1 (EEF1A1), elongation factor 1-alpha 2
(EIF1A2)) and the transcriptional regulators heterogene-
ous nuclear ribonucleoprotein K (HNRPK), y-box binding
protein 1 (YBX1) and proliferation-associated 2G4
(PA2G4) (Figure 4).
The list of proteins used for gene ontology analysis was
also imported into Ingenuity Pathway Analysis (IPA). IPA
integrates proteomics profiles with a manually-curated
database of existing literature. This tool enables the inter-
pretation of data in the context of biological significance.
IPA allows statistical ranking of both "canonical path-
ways" (well-established biochemical pathways) and "net-
Significant alterations in protein localization within 15 minutes of prednisone Exposure Figure 2
Significant alterations in protein localization within 15 minutes of prednisone Exposure. The overall ratio distribu-
tions for cytosolic proteins identified across all time points is shown. Protein ratios outside the range of 0.66 and 1.5 were con-
sidered significant. Results are derived from a single experiment for each time point. Each sample was comprised of SILAC 
labeled and unlabeled proteins.
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works" (protein-protein and gene-protein interactions
suggested by the literature). Top ranked networks are
defined as those showing the greatest number of connec-
tions within a 35 protein 'space'. Analysis of the 69 pro-
teins showing significant subcellular translocation in
response to prednisone resulted in a single highly ranked
network that contained 25 of the 69 proteins imported.
This network contained multiple sub-networks centered
on proteins including actin, myosin, HNRPK and annexin
A2 (ANXA2) (Figure 5). Many of the proteins mentioned
above mapped to this network, further supporting the
hypothesis that protein synthesis and cytoskeletal remod-
eling are significantly affected by prednisone treatment.
While SILAC is one of the most accurate protein quantita-
tive methods, we used immunoblotting as a secondary
method to validate a subset of our data. ANXA2 was cho-
sen due to its central position in the network shown in
Figure 5, as well as the availability of antibody reagents.
The cytosolic, nuclear, membrane/organelle, and
cytoskeletal fractions pre- and post-exposure with gluco-
corticoids were probed for ANXA2 (Figure 6). Consistent
with the mass spectrometry data, we found a 2.7-fold
increase of ANXA2 in the nucleus, however this did not
reach statistical significance by experimental triplicates
due to high variance of the immunoblot results (p = 0.06).
More importantly, immunoblot analysis of the mem-
brane/organelle fraction showed a significant 2.8-fold
decrease of ANXA2 (p = 0.02) (Figure 6). These data dem-
onstrate that prednisone induces rapid intracellular
migration of ANXA2 from the membrane/organelle com-
partment to the nuclear compartment and also validate
the mass spectrometry quantitation findings.
Acute protein stability and translational response to 
prednisone
ANXA2, HNRPK and the majority of proteins networked
with these two proteins are involved in the regulation of
translationally-inactive messenger ribonucleic acids
(mRNAs). We hypothesized that perturbations in transla-
tional machinery would lead to downstream changes in
the translation of inactive mRNA pools. If true, we would
expect to see acute changes in the translation of specific
mRNAs in response to prednisone over this time frame,
possibly involving traffic of mRNAs to or from quiescent
RNA pools.
To test if there was a change in pattern of acute mRNA
translation, C2C12  muscle cells were simultaneously
exposed to prednisone and 35S-Methione/Cysteine for 15
min in the absence of cycloheximide. Transcriptional
inhibitors were not used because they have been shown to
activate transcription of quiescent pools of mRNAs [24].
Cytosolic proteins were analyzed by 2D gels, with fluorog-
Table 1: Top proteins significantly altered in response to prednisone
Fold Change Up-regulated
Accession Molecules FC SD # Pep ID
IPI00421223.2 Tropomyosin 4 5.03 0.10 10
IPI00229509.1 Plectin-1 4.07 0.13 14
IPI00229534.4 Myristoylated alanine-rich C-protein 4.00 0.03 7
IPI00131138.9 Filamin A 3.37 0.07 32
IPI00223253.1 Heterogeneous nuclear ribonucleoprotein K 3.34 0.12 9
IPI00380436.1 Alpha-actinin 1 3.10 0.12 4
IPI00113241.6 Ribosomal protein S19 2.67 0.13 9
IPI00124829.4 Actin-related protein 2/3 complex subunit 3 2.56 0.28 5
IPI00111831.1 Nascent polypeptide-associated complex subunit alpha, muscle-specific form 2.11 0.13 51
IPI00126115.1 Sideroflexin-3 2.11 0.05 6
Fold Change Down-regulated
Accession Molecules FC SD # Pep ID
IPI00284119.6 Troponin C, skeletal muscle -4.35 0.10 13
IPI00312700.3 Myosin light chain 1 -2.78 0.06 11
IPI00228548.5 Enolase 3 -2.77 0.32 28
IPI00225275.4 Glycogen phosphorylase, muscle form -2.76 0.10 23
IPI00319994.5 L-lactate dehydrogenase A chain -2.60 0.24 24
IPI00223757.3 Aldose reductase -2.53 0.28 12
IPI00121788.1 Peroxiredoxin-1 -2.45 0.16 12
IPI00221402.6 Fructose-bisphosphate aldolase A -2.30 0.18 11
IPI00123319.1 Tropomyosin beta chain -2.27 0.23 25
IPI00110990.1 Dual specificity protein phosphatase 3 -2.27 0.10 11
IPI00119667.1 Elongation factor 1-alpha 2 -2.24 0.10 8Proteome Science 2009, 7:26 http://www.proteomesci.com/content/7/1/26
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raphy to detect de novo synthesized proteins over the 15
min time frame. All experiments were carried out in bio-
logical triplicate, and automated quantitative analyses of
autoradiography gels performed by Ludesi.
A total of 832 different spots were detected between the
control and prednisone gels. Analysis was limited to spots
identified in all gels in both groups (n = 274) or those
identified in all three gels from a single group (exposed n
= 83; unexposed n = 81) (n = 438 non-redundant spots).
Fifteen spots had a fold change ≥ 1.5 and p value ≤ 0.05 in
the exposed group when compared to unexposed controls
(Figure 7). These spots were selected for peptide mass fin-
gerprint identification using Coomassie stained gels. Eight
of the fifteen proteins were abundant enough to be
detected on the less sensitive Coomassie stained gel and
could be confidently mapped and excised. Of these eight
proteins, five proteins showed adequate MS/MS results for
unambiguous identification (Table 3).
The 5' untranslated region (UTR) of the genes correspond-
ing to each of the proteins was analyzed for RNA regula-
tory motifs using the publicly available web server
RegRNA http://regrna.mbc.nctu.edu.tw/index.html. Each
of the five proteins contained multiple 5' terminal oli-
gopyrimidine tracts (TOP) (Table 3). Both nasopharyn-
RPS13 increases in the cytosol in response to prednisone Figure 3
RPS13 increases in the cytosol in response to prednisone. Quantitation of the zoom scans for three unique peptides 
identified in the cytosolic fraction for RPS13. The mean ratio for RPS13 was multiplied by each timepoint's normalization factor 
(NF), which was calculated to adjust the overall protein population mean ratio to 1.0. Peptides were normalized to their corre-
sponding baseline peptide at T0, resulting in a normalized peptide ratio (NR). The NR was then converted to a fold change 
(FC). Results showed an increase in RPS13 levels detectable through T15 (15 minutes) post-exposure. Quantitation was per-
formed on the intercalating zoom scans for the corresponding MS2 scan by taking the ratio of the monoisotopic peak of the 
heavy (labeled) peak divided by the monoisotopic peak of the light (unlabeled, prednisone-exposed) peak.
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Temporal profiling of transcriptional/translational proteins showing acute translocation into the cytosol Figure 4
Temporal profiling of transcriptional/translational proteins showing acute translocation into the cytosol. Shown 
are relative ratios of ribosomal proteins and transcriptional regulators with significant changes in the cytosol following expo-
sure to prednisone. All proteins reached their maximum levels at five minutes and returned to baseline levels by 30 minutes.
 
 
Table 2: Transient increase in ribosomal proteins in the cytosol
T5 T15 T30
IPI Accession No. Protein FC p-value FC p-value FC p-value
IPI00111272.1 PREDICTED: similar to 40S ribosomal protein SA 1.87 0.00000 1.26 0.04298 1.13 0.226600
IPI00111412.2 60S ribosomal protein L4 1.91 0.00000 1.38 0.00169 0.97 0.510430
IPI00113241.6 40S ribosomal protein S19 2.60 0.00000 1.04 0.32051 0.97 0.885180
IPI00125901.4 40S ribosomal protein S13 3.17 0.00000 1.20 0.60448 1.04 0.079524
IPI00134599.1 40S ribosomal protein S3 2.10 0.00000 1.42 0.00167 1.13 0.439200
IPI00134607.5 PREDICTED: similar to 40S ribosomal protein S2 1.59 0.00000 1.16 0.09428 0.95 0.476900
IPI00222547.5 60S ribosomal protein L28 2.11 0.00001 1.18 0.00304 0.96 0.816390
IPI00282248.1 PREDICTED: similar to 60S ribosomal protein L6 2.16 0.00000 1.09 0.61050 0.96 0.177500
IPI00308706.3 60S ribosomal protein L5 1.98 0.00000 1.53 0.44499 1.01 0.061444
IPI00331345.4 40S ribosomal protein S3a 1.87 0.00000 1.04 0.00000 1.02 0.889755
IPI00122426.1 60S ribosomal protein L19 1.72 0.00000 0.93 0.65748 0.83 0.321220Proteome Science 2009, 7:26 http://www.proteomesci.com/content/7/1/26
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geal epithelium specific protein 1 (NESG1) and isoform 2
of replication factor C subunit 1(RFC1) also contained
Gamma interferon activated inhibitor of Ceruloplasmin
mRNA translation (GAIT) elements.
Discussion
We defined acute (minutes of treatment exposure time
scale) protein changes in subcellular fractions in response
to prednisone with time series data, enabling some delin-
eation of cause/effect of observed changes in protein sub-
cellular localization. Our experimental design involved a
SILAC strategy to monitor temporal protein translocation
in prednisone-exposed C2C12 cells (Figure 1). We used
stringent criteria for protein identification and quantita-
tion to reduce the number of false positive identifications
and to provide an assessment of variance of peptide ratios
between time points.
The percentage of proteins identified across all time
points (e.g. 0, 5, 15, and 30 min exposure) is low when
compared to the total number of identified proteins
(41.8% in the cytosol and 23.8% in the nucleus) and this
is due to the poor reproducibility when dealing with mul-
tiple subcellular fractionations (see Additional file 1).
However, these percentages are higher than previously
reported values. Currently, there are only a handful of
published papers using a SILAC-based LC-MS/MS in tem-
poral studies. Additionally, not all of these published
papers address protein identification rates across samples
and fractions. A recent paper published from our group
(focused on the endoplasmic stress response) found
Network analysis of translocated proteins Figure 5
Network analysis of translocated proteins. All proteins (n = 69) showing significant translocation in or out of the cytosol 
or nuclei following prednisone exposure were loaded into Ingenuity Pathway Analysis. This analysis queries published protein-
protein or gene-protein interactions between members of the 69 protein set. Proteins were placed in the subcellular fraction 
in which they were found to change abundance. Red indicates an increase in that fraction, green a decrease. This network 
includes a sub-network centered on ANXA2 and is connected with ribosomal proteins and other proteins involved in transla-
tional machinery. White color indicates proteins mapped to the network that were part of the imported data. Solid line indi-
cates a direct interaction between molecules. Dashed lines indicate an indirect interaction between molecules.
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ANXA2 translocates from the membrane/organelle fraction to the nucleus in response to prednisone Figure 6
ANXA2 translocates from the membrane/organelle fraction to the nucleus in response to prednisone. Shown is 
immunoblot analysis of C2C12 subcellular fractions probed for ANXA2 (A), and quantitation of experimental triplicates densi-
tometry (B). ANXA2 was not detected in the cytoskeleton fraction (data not shown). ANXA2 migrated from the membrane/
organelle fraction to the nucleus within 15 minutes of prednisone exposure (**= p ≤ 0.05). Data in Panel B are mean ± SE.
 Proteome Science 2009, 7:26 http://www.proteomesci.com/content/7/1/26
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19.7% of total identified proteins overlapping across four
time points [25]. Another study (focused on concurrent
temporal protein expression patterns during B-cell differ-
entiation) found 23.4% overlapping proteins across five
time points [26]. Our higher percentages could be attrib-
uted to more stringent filtering criteria.
Significantly altered proteins between what and what
were imported into Ingenuity for network analysis. Many
of the molecules in the highest ranked network were
cytoskeleton-related proteins (Table 1; Figure 5). These
proteins, in addition to the numerous other cytoskeleton
proteins found to significantly change localization in
response to prednisone, suggest an acute cytoskeleton
remodeling of muscle cells in response to prednisone
exposure. Glucocorticoid-induced actin remodeling has
not been demonstrated in muscle but has been found in
other tissues. In keratinocytes, glucocorticoids induced
rapid actin assembly in endometrial cells [27,28]. A dose-
dependent decrease in the G/total actin ratio was seen
35S-Methionine/Cysteine labeling of de novo protein translation identifies reduced ANXA6 isoform A protein translation pat- terns Figure 7
35S-Methionine/Cysteine labeling of de novo protein translation identifies reduced ANXA6 isoform A protein 
translation patterns. One of the 5 proteins showing altered translation patterns was Annexin A6 (ANXA6) isoform A which 
decreased 2.23 in response to prednisone. (A) Original prednisone-exposed autoradiography gel. Arrow points to location of 
ANXA6.A. (B) Normalized means of relative protein abundance for triplicate experiments. (C) Enlarged view of the resolved 
ANXA6.A spot of the 3D rendering of the 2D montage.
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Table 3: Altered de novo translation patterns in response to prednisone
Fold Change p-value Protein Accession # C.I #TOP motifs
1.79 0.027 Pyruvate kinase isozyme M2 IPI00407130 98.7 6
-2.26 0.023 Annexin A6 isoform A IPI00649152 100 6
1.68 0.017 Annexin A6 isoform B IPI00310240 100 6
-3.55 0.039 Nasopharyngeal epithelium specific protein 1 IPI00474207 100 6
Control Only 0.046 Isoform 2 of Replication factor C subunit 1 IPI00378168 99.8 4Proteome Science 2009, 7:26 http://www.proteomesci.com/content/7/1/26
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with a concurrent increase in F-actin in as early as 15 min-
utes of exposure.
Numerous studies have implicated the activation of PKC
and PKC-mediated cytoskeleton remodeling in response
to glucocorticoids in non-muscle tissues [10,29-31]. In
the present study, several PKC binding proteins showed
alterations in protein localization, including EEF1A,
EEF1A2, myristoylated alanine-rich C-protein (MARCKS)
and glutaredoxin-3 (GLRX3) in or out of the cytosol.
GLRX3 (also known as PICOT) was shown to bind cal-
cium-independent PKCθ. In unstimulated T-cells, GLRX3
is distinctly localized to the cytoplasm. PKCθ stimulation
results in the co-translocation of PKCθ and GLRX3 to a
submembrane location [32]. In cardiac muscle, GLRX3
interacts with muscle LIM protein located at cardiac Z-
disks, where it interacts with other Z-disk proteins such as
alpha-actinin, zyxin, and T-cap [33]. GLRX3 competitively
displaces calcineurin and disrupts dephosphorylation of
NFAT and subsequent downstream signaling. GLRX3 may
also bind specific PKC isozymes inhibiting downstream
MAPK activity. The author suggests that this scaffolding
domain functions as an inhibitor of the hypertrophic sig-
nal transduction. This model could be applied to the
atrophic response of skeletal muscle to glucocorticoids.
Another PKC substrate, MARCKS, decreased in the
cytosol. MARCKS is an actin filament cross-linking pro-
tein normally localized to focal adhesions at the plasma
membrane. Phosphorylation by PKC inhibits its associa-
tion with actin at the plasma membrane and results in
increased cytosolic localization [34]. Glucocorticoid treat-
ment rapidly increased MARCKS 4.2-fold in the cytosol.
In muscle, PKC-dependent translocation of MARCKS cor-
relates with integrin signaling and actin cytoskeleton
remodeling [35]. MARCKS transcription is downregulated
by glucocorticoids [13]. Other integrin signaling proteins,
including actin related protein complex subunit 3 and
alpha actinin 1 and 4 and numerous cytoskeleton-related
proteins, also significantly altered localization further sug-
gesting an acute cytoskeletal remodeling occurring. Taken
together, our data suggests there is a potential non-tran-
scriptional PKC-mediated cytoskeletal remodeling occur-
ring within minutes of prednisone exposure. However,
further experiments are required to validate this result and
delineate which molecular mechanisms are responsible.
In addition to the cytoskeletal and cytoskeleton-bound
proteins, there were significant changes seen in proteins
involved in protein synthesis. Multiple ribosomal pro-
teins and transcriptional regulators increased in the
cytosolic fraction upon glucocorticoid treatment (Table 2;
Figures 3 and 4). All of these proteins shared a common
temporal pattern, with the greatest increase in the cytosol
seen within 5 minutes of prednisone exposure and return-
ing to basal levels by 30 minutes (Figures 3 and 4). We
hypothesize that the ribosomal proteins are translocating
into the cytosolic fraction from either the cytoskeleton or
the membrane/organelle fraction. An alternative interpre-
tation is that these proteins may be stabilized by drug
treatment. Unfortunately, antibody reagents are not cur-
rently available to test these models. We were able to val-
idate the ANXA2 mass spectrometry findings using
immunoblot, and by testing additional fractions showed
that the intracellular movement was likely translocating
from the membrane/organelle to the nuclear compart-
ment (Figure 6). ANXA2 has been observed in multiple
subcellular compartments and is known to traffic between
the cytosol and nucleus [36]. Nuclear retention of ANXA2
results in reduced cell proliferation in prostrate cells [37].
Extrapolating from these data, the steroid-induced migra-
tion of ANXA2 from the membrane/organelles to the
nucleus may be, at least in part, responsible for the
reduced C2C12 proliferation observed in response to glu-
cocorticoids [38]. This is the first report that we are aware
of demonstrating glucocorticoid-induced alteration of
ANXA2 localization in skeletal muscle.
Glucocorticoids have a receptor-mediated transcriptional
response that alters transcriptional profiles. This is the first
report demonstrating that ribosomal proteins and tran-
scriptional regulators (i.e. ANXA2, HNRPK, YBX1, etc)
have a non-transcriptional mechanism of action. We
hypothesized that the observed rapid increase of ribos-
omal proteins into the cytosol by 5 minutes of steroid
treatment could lead to acute changes in mRNA transla-
tion patterns, perhaps via sequestering of mRNAs to or
from inactive mRNA pools. To test this, we exposed C2C12
myotubes with 35S-Methione/Cysteine and prednisone
for 15 minutes to label all de novo protein translation
products rapidly induced by drug treatment. Fifteen spots
showed a fold change ≥ 1.5 and p-value ≤ 0.05 and, of
these 15, five were abundant enough to identify by LC-
MS/MS (Table 3; Figure 7).
If these five proteins were translated from quiescent RNA
pools, then the corresponding 5' UTR of the mRNAs
would be expected to contain TOP motifs commonly
associated with components of these inactive mRNA
pools [39]. All five proteins showing drug-induced acute
translation showed multiple TOP motifs in the 5'UTR of
their corresponding mRNAs. 6.6% of all mRNAs show ≥ 1
TOP motif(s) [40], and our finding of 5/5 showing multi-
ple TOP motifs was compelling (probability of 1 in 1.2 ×
10-6). Our data suggests that prednisone is sequestering
mRNAs to or from the inactive mRNA pools, leading to a
rapid shift in ribosomal proteins to the cytosol. This
response appears short-lived, with re-equilibration of the
protein translocation pattern within 30 minutes of treat-Proteome Science 2009, 7:26 http://www.proteomesci.com/content/7/1/26
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ment. However, de novo protein translation would be
expected to show a more sustained effect.
Translation of TOP mRNAs is dependent upon the growth
status of the cell. In growing cells, TOP mRNAs are local-
ized at polysomes and are actively transcribed whereas in
quiescent cells, TOP mRNAs are localized at small polys-
omes and translationally-inactive messenger ribonucleo-
proteins, where they can be stored for up to a week [41].
Many of the proteins involved in proteins synthesis are
represented in the ANXA2-centered sub-network (Figure
5) described above, and are involved in translation of
inactive mRNAs. ANXA2 and PA2G4 are both RNA-bind-
ing proteins that are present in pre-ribosomal ribonucleo-
protein complexes [42,43].
Three of the de novo-translated proteins showed an
increase in translation, while two showed a significantly
decreased rate. The two negatively regulated proteins
(NESG1 and RFC1) contain GAIT elements in their 5'
UTR. A GAIT element is a cis-acting RNA element involved
in selective translational silencing of ceruloplasmin by
interferon gamma-activated inhibitor of translation [44].
It has been suggested that the translational silencing of
ceruloplasmin and other GAIT-containing transcripts may
aid in resolving the local inflammatory response. It is pos-
sible that decreases of translation observed in NESG1 and
isoform 2 of RFC1 could be attributed to translation
silencing via this same mechanism. Overall, it seems that
5'TOP motifs are involved in the acute non-translational
response of myotubes to prednisone, with additional
motifs controlling whether a shift from or to the quiescent
mRNA pools is observed.
Conclusion
In summary, we describe a systematic approach for mon-
itoring intracellular protein translocation using SILAC
and apply this to the acute non-transcriptional response
of myogenic cells to prednisone. We found an acute trans-
location of many cytoskeleton and cytoskeleton-bound
proteins indicative of rapid remodeling. Additionally, we
discovered the translocation of ribosomal proteins into
the cytosol, which was commensurate with de novo trans-
lation patterns in a subset of mRNAs. These mRNAs were
translated within 15 minutes of exposure, and showed
features consistent with transport in or out of quiescent
pools. The translocation of ribosomal proteins rapidly
returned to baseline by 30 minutes, while the de novo
translation patterns likely have a more persistent drug-
induced effect.
Methods
Tissue culture methods
Mouse C2C12 myoblasts were grown in DMEM supple-
mented with 10% FBS and 1% Penicillin/Streptomycin.
Concurrently, equal amounts of mouse C2C12 cells were
incubated in custom-made DMEM medium depleted of
Arg and Lys and supplemented with 13C6-Arg (147.5 ug/
mL) and 13C6, 15N2-Lys (91.25 ug/mL), as well as 10% FBS
and 100 U/mL each of penicillin/streptomycin. The pres-
ence of 10% whole serum in the culture medium does not
interfere with the incorporation of the exogenous stable
isotope labeled amino acids and can be used in place of
dialyzed FBS serum [45]. All cells were sub-cultured for
five passages to allow full incorporation of isotopes into
the cells grown in labeled medium. At five passages, full
isotope incorporation was achieved. All cells were serum-
starved into differentiation using DMEM supplemented
with 2% horse serum and 1% Penicillin/Streptomycin.
Steroid exposure and subcellular fractionation
On day five of differentiation, both SILAC labeled and
non-labeled cells were exposed for 1 hr to 35 μM
cycloheximide to arrest translation prior to steroid treat-
ment. Unlabeled myotubes were exposed to 1 μM of Pred-
nisone for 5, 15, or 30 minutes while SILAC labeled cells
were unexposed. At each time point steroid-exposed cells
were mixed, at 1:1 ratio (w/w), with the non-exposed
SILAC labeled cells fractionated using the differential
detergent extraction method [23]. Mixing samples prior to
fractionation controls for differences in experimental han-
dling. For a control, labeled and unlabeled cells at the 0
minute time point were exposed with cycloheximide but
not prednisone. Cytosolic and nuclear fractions were
processed for LC-MS/MS analysis.
Peptide extraction
100 μg of total protein for each fraction and time point
was desalted and dry vacuumed to completion, brought
up in 30 uL Laemmle buffer containing 50 mM DTT, and
incubated for 30 min at room temperature. 1D protein
separation was performed using a precast 4–12% SDS-
PAGE gel, fixed using methanol:water:acetic acid
(45:50:5, vol/vol/vol) for 30 min and stained with
Coomassie blue. The fractionated lane was excised into 35
bands. In-gel digestion was performed [46]. Extracted
peptides were dissolved in 0.1% TFA.
LC-MS/MS analysis quantitative and statistical analysis of 
proteins
All analyses were carried out on a Thermo LTQ Linear ion-
trap connected to a nano-LC system. Each sample was
injected via an autosampler and loaded onto a C18 trap
column (5 μm, 300 μm i.d. × 5 mm), for 6 min at a flow
rate of 10 μL/min, 100% A. The sample was subsequently
separated by a C18 reverse-phase column (3.5 μm, 100
μm × 15 cm) at a flow rate of 200 nL/min. The mobile
phases consisted of water with 0.1% formic acid (A) and
90% acetonitrile with 0.1% formic acid (B). A 100 min
linear gradient from 5 to 60% B was typically employed.Proteome Science 2009, 7:26 http://www.proteomesci.com/content/7/1/26
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The LTQ was operated in data-dependent mode in which
one cycle of experiments consisted of one full-MS survey
and subsequently three sequential pairs of intercalated
zoom scans and MS/MS experiments. The targeted ion
counts in the ion trap during full-MS, zoom scan, and MS/
MS were 30000, 3000, and 10000, respectively. Peptides
were fragmented in the linear ion trap using collision-
induced dissociation with the collision gas (helium) pres-
sure set at 1.3 milliTorrs and the normalized collision
energy value set at 35%. The zoom scan events are of
higher resolution higher than and were used to determine
the charge state of the ion as well as the ratio of labeled to
unlabeled peptide pairs.
Data base search and quantitative analysis
MS/MS spectra files from each LC run were searched using
Sequest against the publicly available mouse EMBL-EBI
International Protein Index (IPI) database v3.22 with the
following variable parameters: oxidized methionine (15.0
Da) and phosphorylation of serine, threonine, and tyro-
sine (80.0 Da), and [13C6, 15N2]-lysine (8.0 Da) and
[13C6]-arginine (6.0 Da) as variable modifications, fully
enzymatic trypsin cleavage specificity allowing for two
missed cleavages and 0.8 Da for MS/MS ions. Results were
filtered using the following criteria: different peptides,
delta CN = 0.1, XCorr vs. Charge State = 1.9, 2.5, and 3.5
(for singly, double, and triply charged peptides respec-
tively), peptide probability = 0.001, number of different
peptides = 3. Manual quantitation was performed, where
the ratios of at least 3 different peptides were quantitated
by dividing the relative abundance of the monoisotopic
peak of the heavy peptide by the relative abundance of the
monoisotopic peak of the light peptide. Mean and stand-
ard deviation of the unexposed/exposed peptide ratios
were calculated for each identified protein using all pep-
tides available (n ≥ 3). To adjust for any error in the mix-
ing of labeled and unlabeled cells prior to subcellular
fractionation, the average ratio obtained for each protein
in a given subcellular fraction and at a given time point
was normalized to the average median mean value
obtained for that data set. Protein ratios in each of the ster-
oid-exposed sets (T5, T15, and T30) were normalized to
the control (T0) by subtracting the control mean for a
given protein from the steroid-exposed mean of the same
protein. This normalized ratio was used to calculate a z-
score and corresponding p-value, indicating if each pro-
tein in the steroid-exposed condition was significantly dif-
ferent from the unexposed population. Fold changes for
all proteins were also calculated. Results are derived from
a single experiment for each time point. Each sample is
comprised of SILAC labeled and unlabeled proteins.
Immunoblot analysis
C2C12 myoblasts were grown and differentiated under
conditions described above. Five days post-differentiated,
myotubes were exposed to prednisone for 15 minutes and
fractionated using the differential detergent fractionation
as described above. Positive controls were 30 ug total pro-
tein from NIH/3T3 whole cell lysates. 30 ug of total pro-
tein from each subcellular fraction was separated under
reducing conditions via one dimensional separation on a
10% SDS-PAGE gel. Proteins were transferred onto a
PVDF membrane and blocked in 5% non-fat dried milk in
TBS/0.05% Tween 20 (TBST) for 1 hour. Membranes were
incubated overnight with an ANXA2 specific antibody;
Santa Cruz Biotechnology Inc.). After three washes with
TBST, membranes were incubated at room temperature
for 1 h using a peroxidase-labeled (HRP) secondary anti-
body (Santa Cruz) in 5% non-fat dried milk in TBST. After
three washes in TBST, bound antibodies were detected by
the chemiluminescent method (ECL, Amersham Bio-
sciences). Quantitative analyses were performed using
Bio-Rad GS imaging densitometer using QuantOne 4.6.2
software.
Labeling of acute de novo protein translation
C2C12  myotubes were grown in unlabeled media as
described above. On day five post-differentiation, myo-
tubes were exposed to either 250 mCi 35S-Methionine/
Cysteine or 1 μM Prednisone and 250 mCi 35S-Methio-
nine/Cysteine for 15 minutes. Each condition was carried
out in triplicate cultures. Cytosolic proteins were isolated
as described above. Total cytosolic protein (200 μg) was
buffer-exchanged (Tris-HCl, pH 7.4), concentrated, and
then solubilized in isoelectric focusing rehydration buffer
using a solution consisting of 7 mol/l urea, 2 mol/l thiou-
rea, 1% (wt/vol) ASB-14, 0.5% (vol/vol) Triton X-100, 40
mmol/l Tris base, 30 mmol/l DTT, and 0.5% (vol/vol)
ampholytes 3–10. Samples were then loaded onto a 17-
cm, pH 3–10 NL Immobilized pH Gradient strip and left
under mineral oil overnight. IEF was conducted for a total
of 100,000 Vh (volt-hours) at 20°C. Strips were incubated
for 15 min in equilibration buffer (6 mol/l urea, 2% [wt/
vol] SDS, 20% [vol/vol] glycerol, 0.15 mol/l bis-Tris, and
0.1 mol/l HCl) at 20°C, first with 65 mmol/l DTT and sec-
ond with 243 mmol/l iodoacetamide. Strips were inserted
into 12% SDS-PAGE gels and two-dimensional gels were
run according to manufacturer instructions. After protein
separation, the gel slabs were fixed in a solution of meth-
anol:water:acetic acid (45:50:5, vol/vol/vol) and then in
Amplify Fluorography (Amersham Biosciences) for 30
min. Gels were dried overnight under vacuum seal and
stored at -80°C for 25 hrs prior to film development.
2D-Gel quantification and analysis
Gel images were analyzed by Ludesi. For spot identifica-
tion, the same experimental design described above was
used but without radioactivity. Non-radioactive gels fol-
lowed the same procedure with the following exceptions.
Cells were exposed to only prednisone for 15 min. AfterProteome Science 2009, 7:26 http://www.proteomesci.com/content/7/1/26
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second-dimension separation, gels were fixed (45%
dH20/5% acetic acid/50% methanol) followed by three
washes for 5 min in deionized water. Staining was per-
formed with Coomassie Blue followed by ample rinsing
with deionized water until the desired contrast was
obtained.
Spots were excised and transferred to a microcentrifuge
tube containing 100 μl of deionized water. Tryptic diges-
tion was performed as described previously [46] and pep-
tides were extracted and then dried by vacuum
centrifugation. Dried peptides were subsequently dis-
solved in 10 μl of 0.1% trifluoroacetic acid and desalted
using C18 ZipTip micropipette tips following the manufac-
turer's instructions. Aliquots of peptide solutions were
spotted on the matrix-assisted laser desorption/ionization
(MALDI) plate. Mass spectrometry (MS) and tandem
mass spectrometry (MS/MS) analyses were performed on
a 4700 ABI time-of-flight (TOF)-TOF mass spectrometer
equipped with a Nd:YAG 200 Hz laser. The instrument
was operated with delayed extraction in reflectron positive
ion mode. A mixture of standard peptides was used to
externally calibrate the instrument. Protein identification
was carried out using GPS explorer v3.6 and searched
against the IPI database v3.22. Both MS and MS/MS data
were used for protein identification. In-gel digestion was
performed as described above.
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